Key facts
- It has raised $4.8M; the latest was Early Stage VC ($1.5M) in May 2025.
- Notable investors include Stead Impact Ventures and Foundation.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Cato (Distributors (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Cato (Distributors (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cato (Distributors (Healthcare))
Operator of the healthcare supply chain technology intended to streamline the procurement cycle and address critical shortages across the supply chain. The company offers a nationwide sourcing network with strengths in customer service, back-order product fulfillment, and supplier aggregation, providing healthcare providers with consistent patient care, procurement, and access to trusted product alternatives.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2024
- Employees
- 20
- Website
- catosupply.com/
- Ownership
- Privately Held (backing)
Cato (Distributors (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cato (Distributors (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cato (Distributors (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.